United States HSV Testing Market to Grow with a CAGR of 4.36% through 2030
Surge in
research and development activities is expected to drive the United States HSV
Testing Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “United States HSV Testing Market – By Region, Competition,
Forecast & Opportunities, 2030F”, the United States HSV Testing Market
stood at USD 203.45 Million in 2024 and is anticipated to grow with a CAGR of 4.36%
through 2030. Initiatives taken by government based on HSV testing has led to
favorable market conditions for the United States HSV Testing Market. Several
factors contribute to the growth of various HSV testing products.
One of the
primary areas of focus in R&D is improving diagnostic accuracy. Traditional
serological tests have limitations in sensitivity and specificity, particularly
when distinguishing between HSV-1 and HSV-2. In response, ongoing research has
led to the development of advanced molecular diagnostics, such as PCR-based
assays, which offer faster results and greater reliability. These innovations
are not only enhancing clinical decision-making but also increasing the overall
confidence in HSV testing.
One major step taken by federal health agencies is the formal inclusion of HSV in the national STI response framework. By integrating HSV into the strategic plans that guide STI prevention and treatment across the country, the government has elevated its status from an overlooked condition to a recognized public health priority. This inclusion ensures that HSV is addressed through coordinated policies, funding opportunities, education programs, and data collection efforts at both the state and federal levels.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States HSV Testing Market”
The United
States HSV Testing Market is segmented into sample type, test type, regional
distribution, and company.
Based
on Sample Type, Swabs have emerged as the dominating segment in the United
States HSV Testing Market in 2024. This is due to their widespread clinical
use, high diagnostic accuracy for active infections, and ease of sample
collection. Swab-based testing, particularly using lesion or genital swabs, is
the gold standard for diagnosing active herpes simplex virus (HSV) infections,
as it allows for direct detection of the virus through molecular methods such
as PCR. The ability to provide rapid and reliable results during symptomatic
outbreaks has made swabs the preferred sample type in urgent care, sexual
health clinics, and hospital settings.
Based on Region,
Northeast have emerged as the fastest growing region in the United States HSV
Testing Market in 2024. This is due to a combination of high population
density, increased public health awareness, and strong access to healthcare
infrastructure. The region is home to some of the country’s leading medical
institutions and diagnostic laboratories, which support early detection and
routine screening efforts. Additionally, proactive public health campaigns and
educational initiatives have led to greater awareness of sexually transmitted
infections, including herpes simplex virus, prompting more individuals to seek
testing.
Major companies
operating in United States HSV Testing Market are:
- F. Hoffmann-La
Roche Ltd
- Abbott
Laboratories
- Thermo Fisher
Scientific Inc.
- Becton,
Dickinson and Company
- Bio-Rad
Laboratories, Inc
- BIOMÉRIEUX
- Hologic, Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“Nanotechnology
is beginning to play a transformative role in the United States HSV testing
market by enhancing the sensitivity, speed, and accessibility of diagnostic
tools. Through the application of nanoscale materials such as gold
nanoparticles and quantum dots developers are improving the detection of HSV
biomarkers with greater accuracy, even at low viral loads. These advancements
support earlier diagnosis and reduce false negatives, which is particularly
important given the often asymptomatic nature of HSV infections”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“United States
HSV Testing Market By Sample Type (Blood, Swabs, Cerebrospinal Fluid, Others),
By Test Type (Serological Tests, Direct Detection Tests, Point-of-Care Tests,
Others), By Region and Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of United States HSV Testing Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United States HSV Testing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com